This new edition of Non-prescription Medicines has been revised and updated to reflect amendments in legal category status of several products from prescription-only (POM) to pharmacy sale (P) status. Over-the-counter (OTC) medicines currently available in the UK are reviewed in alphabetically arranged chapters on the conditions that they are licensed to treat. 44 common conditions are covered and new chapters on Chlamydia, Obesity and Benign Prostatic Hyperplasia have been added. Each chapter includes:* an introduction to the condition* detailed description of the available products, including mode of action, side-effects, cautions and contraindications, interactions and dosage* product selection points* product recommendations. Non-prescription Medicines is the only publication in the UK that deals with available OTC medicines comprehensively and in depth. This vital resource will enable pharmacists, GPs, nurses and other healthcare professionals to make well-informed recommendations and to give sound advice to their patients. Updates are available online in January and June at (INSERT WEB ADDRESS)Alan Nathan is a freelance pharmacy writer and Consultant, London, UK.

Is there really a safer, more effective natural alternative to most prescription and over-the-counter medicines?The answer is yes. In this groundbreaking book, Michael T. Murray provides specific natural alternatives to some of the drugs most used by Americans, including Tagamet, Prednisone, Seldane, and Zantac, as well as alternatives to over-the-counter drugs used to treat acne, high cholesterol, hay fever, heartburn, insomnia, and many other common ailments. Naturopathic physician Michael T. Murray discusses the effectiveness, and the unwanted side effects, of many of the drugs used today. He then shows how these drugs can be replaced with less expensive natural remedies whose medicinal benefits have been proven in clinical studies. Murray discusses dozens of herbal remedies, vitamins and minerals, extracts, and ointments, and shows how each can be used to bring relief from specific ailments. With easy-to-understand charts, graphs, and tables throughout, the book offers detailed, practical information that will help readers live a fuller, healthier life -- free from pharmaceutical medicines. As Dr. Alan R. Gaby writes in his Foreword: "Because of the efforts of Dr. Murray and others, the medical profession is slowly becoming aware that there are legitimate alternatives to drugs and surgery. As the research and data supporting natural medicine continue to increase, and as the limitations and dangers of conventional medicine become more widely appreciated, natural medicine will emerge as the only reasonable alternative."

Following the successful format of "The Pill Book", this unique reference profiles the top 200 over-the-counter medications. These profiles include a description of the drug and how it works, dosages, side effects, information relevant to children, the elderly, and people with allergies, cautions and warnings, and food interactions. A second section lists the active ingredients of the pills, and a 32-page full-color photo insert ensures easy recognition.

As a working parent of 4-year-old triplet daughters, I understand time management presents one of the greatest barriers to my pharmacology students' success. Many students feel that cold sense of overwhelm and information overload. This easy-to-read guide organizes pharmacology into manageable, logical steps you can fit in short pockets of time. The proven system helps you memorize medications quickly and form immediate connections. With mnemonics from students and instructors, you'll see how both sides approach learning. After you've finished the 200 Top Drugs in this book, reading pharmacology exam questions will seem like reading plain English. You'll have a new understanding of pharmacology to do better in class, clinical and your board exam. You'll feel the confidence you'd hoped for as a future health professional. For patients and caregivers, this book provides a means to memorize medications to quickly and articulately communicate with your health providers.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

A STEP-BY-STEP GUIDE TO IMPLEMENTING ADVANCED PHARMACY SERVICES IN COMMUNITY AND CLINIC SETTINGS Community and Clinical Pharmacy Services teaches pharmacy students and practicing pharmacists how to provide advanced levels of pharmacy services in community and clinic settings designed to help patients achieve specific health goals and treat common disease states. This unique text provides practical--rather than merely ideological--ways for pharmacists to utilize their extensive clinical knowledge and fill a major gap in American health care. It discusses barriers, necessary skills, required knowledge, and issues related to preparation, interventions, patient outcomes, economic aspects, and marketing considerations for therapeutic areas commonly addressed in the outpatient setting. The beginning of the book delves into the general management skills necessary to provide and implement advanced patient care services, including documentation, patient interviewing, and medication therapy management. Important chapters discuss disease states that would most likely be amenable to development of pharmacy services, including: Asthma Smoking Cessation Diabetes Hypertension Osteoporosis Obesity Also covered are immunizations, anticoagulation, and cardiometabolic services. The disease state chapters include learning aids such as summary points, first-hand accounts from experienced pharmacists who have implemented pharmacy services for that particular condition, a simulated patient case, and multiple-choice questions.

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.